- Home
- XGN vs SXTC Comparison
XGN vs SXTC Comparison
Compare XGN & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XGN
- SXTC
- Stock Information
- Founded
- XGN 2002
- SXTC 2005
- Country
- XGN United States
- SXTC China
- Employees
- XGN N/A
- SXTC N/A
- Industry
- XGN Medical Specialities
- SXTC Biotechnology: Pharmaceutical Preparations
- Sector
- XGN Health Care
- SXTC Health Care
- Exchange
- XGN Nasdaq
- SXTC Nasdaq
- Market Cap
- XGN 210.4M
- SXTC 184.5M
- IPO Year
- XGN 2019
- SXTC 2019
- Fundamental
- Price
- XGN $11.04
- SXTC $1.46
- Analyst Decision
- XGN Strong Buy
- SXTC
- Analyst Count
- XGN 5
- SXTC 0
- Target Price
- XGN $12.40
- SXTC N/A
- AVG Volume (30 Days)
- XGN 258.8K
- SXTC 58.4K
- Earning Date
- XGN 11-11-2025
- SXTC 01-01-0001
- Dividend Yield
- XGN N/A
- SXTC N/A
- EPS Growth
- XGN N/A
- SXTC N/A
- EPS
- XGN N/A
- SXTC N/A
- Revenue
- XGN $58,862,000.00
- SXTC $1,740,907.00
- Revenue This Year
- XGN $22.28
- SXTC N/A
- Revenue Next Year
- XGN $14.03
- SXTC N/A
- P/E Ratio
- XGN N/A
- SXTC N/A
- Revenue Growth
- XGN 3.89
- SXTC N/A
- 52 Week Low
- XGN $2.38
- SXTC $0.95
- 52 Week High
- XGN $11.28
- SXTC $7.84
- Technical
- Relative Strength Index (RSI)
- XGN 64.51
- SXTC 39.38
- Support Level
- XGN $10.63
- SXTC $1.51
- Resistance Level
- XGN $11.28
- SXTC $1.68
- Average True Range (ATR)
- XGN 0.38
- SXTC 0.16
- MACD
- XGN -0.00
- SXTC -0.03
- Stochastic Oscillator
- XGN 80.41
- SXTC 15.83
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.